A retrospective cohort suggests adjuvant chemotherapy should not be routine after resection of appendiceal adenocarcinoma regardless of local extent, as risk of relapse is very low with or without it, with the exception of uncommon recognized high-risk histologic and/or molecular subtypes. | Khoury, JAMA Surg 2026
